Our head of markets names the company earnings and big events to watch closely in the days ahead.
- Your vote counts: Babcock, Moonpig, AO World, Novacyt, Diageo
- Shareholder voting & information. Have your say on the companies you invest in
- Fund managers slow to cut equities despite being bearish on economy
- Take control of your retirement planning with our award-winning, low-cost personal pension
Monday 20 September
Finsbury Food, Frenkel Topping, Ingenta, Open Orphan, Silver Bullet Data Services, Wilmington
BlueRock Diamonds, Cohort, Home REIT, IG Design, Redde Northgate
Tuesday 21 September
Alliance Pharma, Alphawave IP, ASA International, Cambridge Cognition Holdings, Compass Group (LSE:CPG), Craneware, Dignity, Fintel, JTC, Kape Technologies, Kingfisher (LSE:KGF), Learning Technologies, Litigation Capital Management, M&C Saatchi, PensionBee, Personal Group, SIG, Time FinancE
Appreciate, Augmentum Fintech, Kin & Carta, Knights Group, Manolete Partners, Meggitt, Oxford Instruments, Regional REIT
Wednesday 22 September
Alfa Financial Software, DeepMatter Group, ECSC Group, Halma, Igas Energy, Mission Group, Oxford Biomedica, Pennant International, Plant Health Care, PZ Cussons, Quixant, Saga, Strix Group, Ten Entertainment, Trellus Health, WANdisco, Warpaint London
Babcock International, Civitas Social Housing, IG Group, Ilika, Miton UK MicroCap Trust, Oberon Investments, Seed Innovations, Shearwater, SRT Marine Systems, Stanley Gibbons, Studio Retail Group, Worsley Investors
Thursday 23 September
UK interest rate decision
Aquis Exchange, Arecor Therapeutics, City Pub Group, CVS Group, DFS Furniture, Distribution Finance Capital, eve Sleep, Harbour Energy, Investec, Playtech, Royal Mail, Safestyle UK, Supermarket Income REIT, Xeros Technology, XLMedia
Adept Technology, Alpha Financial Markets Consulting, Begbies Traynor, Bradda Head, Colefax, daVictus, Empyrean Energy, Enteq Upstream, FinnCap, Fuller Smith & Turner, Kainos, President Energy, Trakm8, Versarien
Friday 24 September
Accrol Group Holdings, BH Macro, Fusion Antibodies, In The Style Group, OTAQ
These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.
Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.